NCLEX Review Guide: Acne Management

Etiology and Development

• Acne vulgaris is a chronic inflammatory skin condition that develops when hair follicles become clogged with oil and dead skin cells. The pathogenesis involves four primary factors: excessive sebum production, follicular hyperkeratinization, colonization of Cutibacterium acnes (formerly Propionibacterium acnes), and the release of inflammatory mediators.
• Hormonal influence, particularly androgens, stimulates sebaceous gland activity leading to increased sebum production. This hormonal component explains why acne commonly appears during puberty and may worsen with menstrual cycles in females.

Clinical Presentation

• Acne lesions are classified as non-inflammatory (comedones) or inflammatory (papules, pustules, nodules, and cysts). Comedones present as either open (blackheads) or closed (whiteheads) lesions, while inflammatory lesions appear as red, sometimes painful bumps of varying size.
• Distribution typically affects sebum-rich areas including the face, neck, chest, upper back, and shoulders. Severity ranges from mild (primarily comedonal) to severe (nodular/cystic) with potential for scarring and significant psychosocial impact.

Clinical Assessment

• Assessment involves evaluating lesion type, distribution, severity, and exacerbating factors. The nurse should document the predominant lesion types, affected areas, and severity using standardized scales such as the Global Acne Severity Scale or the Comprehensive Acne Severity Scale.
• History-taking should include onset, duration, previous treatments, medication use (particularly corticosteroids, androgens, lithium, and anticonvulsants), family history, menstrual patterns in females, and psychosocial impact on the patient.

Differential Diagnosis

• Conditions that may mimic acne include rosacea (facial erythema, telangiectasia, papules, pustules, but no comedones), folliculitis (bacterial or fungal infection of hair follicles), and perioral dermatitis (small papules and pustules around the mouth).
• Acne-like eruptions may also result from medication side effects (steroid-induced acne) or underlying endocrine disorders such as polycystic ovary syndrome (PCOS) or congenital adrenal hyperplasia, which should be considered in cases with sudden onset, atypical distribution, or treatment resistance.

Topical Treatments

• Retinoids (tretinoin, adapalene, tazarotene) normalize follicular keratinization and have anti-inflammatory properties. They are first-line therapy for comedonal acne and are effective maintenance therapy, but can cause initial irritation, dryness, and photosensitivity.
• Benzoyl peroxide has bactericidal activity against C. acnes and mild comedolytic effects. Available in concentrations from 2.5% to 10%, it may cause dryness, irritation, and bleaching of fabrics.
• Topical antibiotics (clindamycin, erythromycin) reduce C. acnes colonization and have anti-inflammatory properties. They should be used in combination with benzoyl peroxide to reduce antibiotic resistance.
• Azelaic acid has antimicrobial, anti-inflammatory, and mild comedolytic properties. It is particularly useful in patients with post-inflammatory hyperpigmentation or sensitive skin.

Systemic Treatments

• Oral antibiotics (doxycycline, minocycline, tetracycline) are indicated for moderate to severe inflammatory acne or widespread disease. They should be limited to 3-6 months to minimize antibiotic resistance and should be combined with topical non-antibiotic treatments.
• Hormonal therapy (combined oral contraceptives, spironolactone) is effective for females with hormonal acne patterns. Combined oral contraceptives containing ethinyl estradiol with norgestimate, norethindrone acetate, or drospirenone are FDA-approved for acne treatment.
• Isotretinoin is reserved for severe nodular/cystic acne or treatment-resistant moderate acne. It requires strict monitoring due to potential serious adverse effects including teratogenicity, which necessitates participation in the iPLEDGE program for all patients.

Patient Education

• Educate patients on proper skin care, including gentle cleansing twice daily with a mild, pH-balanced cleanser. Avoid harsh scrubbing, which can irritate skin and potentially worsen inflammation. Recommend oil-free, non-comedogenic moisturizers and sunscreen.
• Provide realistic expectations regarding treatment timeline, emphasizing that most acne treatments require 6-8 weeks to show significant improvement. Stress the importance of adherence to the treatment regimen even when initial irritation occurs with topical retinoids.

Patient Instructions for Topical Medication Application:

1. Wash hands thoroughly before application
2. Cleanse affected area with a gentle cleanser and pat dry
3. Wait 20-30 minutes after washing to ensure skin is completely dry (especially before applying retinoids)
4. Apply a pea-sized amount of medication for the entire face
5. Spread medication evenly using fingertips, avoiding the eyes, lips, and nostrils
6. Wash hands after application
7. Apply moisturizer if prescribed by provider (usually after medication has dried)

Monitoring and Follow-up

• For patients on isotretinoin, monitor for adverse effects including mucocutaneous effects (dry lips, skin, eyes), laboratory abnormalities (elevated triglycerides, liver enzymes), and psychological changes. Baseline and periodic laboratory tests include pregnancy test, lipid panel, and liver function tests.
• For patients on hormonal therapy, monitor for signs of thromboembolism (leg pain, chest pain, shortness of breath) with combined oral contraceptives and hyperkalemia with spironolactone, particularly if combined with other potassium-sparing medications.

Psychosocial Support

• Assess for psychological impact of acne, which may include decreased self-esteem, social withdrawal, anxiety, and depression. Severe acne is associated with higher rates of depression and suicidal ideation, requiring appropriate screening and referral.
• Provide empathetic communication, emphasizing that acne is a medical condition requiring treatment rather than a result of poor hygiene. Connect patients with support resources and consider referral to mental health services when significant psychological distress is present.

Acne vs. Rosacea

Medication Misconceptions

• Myth: Antibiotics alone are sufficient for acne treatment. Reality: Antibiotic resistance is common with C. acnes, and antibiotics should always be combined with benzoyl peroxide and/or retinoids. Oral antibiotics should be limited to 3-6 months of use.
• Myth: Initial worsening with retinoids means the treatment is harmful. Reality: Retinoids can cause a temporary "purging" effect as microcomedones are brought to the surface. This typically resolves within 4-6 weeks and should not lead to discontinuation.

Priority Nursing Interventions

• When answering NCLEX questions about acne management, prioritize patient safety, especially with high-risk medications like isotretinoin. Questions may focus on appropriate monitoring, contraindication awareness, and patient education regarding serious adverse effects.
• For questions addressing patient education, prioritize realistic expectations about treatment timeline, proper administration techniques, and adherence strategies. Remember that psychosocial support is an essential component of comprehensive acne care.

Common NCLEX Question Themes

• NCLEX questions often focus on identifying appropriate treatments based on acne severity and type. Remember that mild comedonal acne typically requires topical retinoids, while moderate-severe inflammatory acne may require combination therapy with oral antibiotics or hormonal treatments.
• Questions may assess knowledge of drug interactions and contraindications, such as tetracycline antibiotics with dairy products or isotretinoin with vitamin A supplements. Be prepared to identify patients who require special monitoring (e.g., females of childbearing potential on isotretinoin).

• Acne vulgaris results from four primary factors: excessive sebum production, follicular hyperkeratinization, C. acnes colonization, and inflammation. Clinical presentation includes non-inflammatory comedones and inflammatory lesions (papules, pustules, nodules, cysts).
• Treatment should be tailored to acne severity and type, with topical retinoids as first-line for comedonal acne and combination therapy for moderate-severe inflammatory acne. Treatment response typically takes 6-8 weeks.
• High-risk medications like isotretinoin require strict monitoring for adverse effects, including mandatory participation in the iPLEDGE program due to teratogenicity risks.
• Patient education should emphasize gentle skin care, proper medication application, realistic expectations, and adherence despite initial irritation with topical treatments.
• Comprehensive management includes addressing the psychosocial impact of acne, which may include decreased self-esteem, social withdrawal, anxiety, and depression.